RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:ENDPOINTS NEWS Jan 31, 2024BottomBroker wrote: How do you explain the share price since the move to the Nasdaq? It was at $6-8 when first listed.
SINCE then, Promis has:
- received approval for an IND from the FDA
- released postitive pre-clinical data
- started Phase 1 trials
Pretty good news, right?
Well, as everyone knows, the share price has gone nowhere but down - almost back to penny-stock status not too long ago - and now is just barely keeping its head above Nasdaq-delisting terrority.
I don't know about anyone else, but that doesn't make a whole lot of sense to me.
The stock went from $8.14 on April 27, 2023, to:
On July 7, 2023, joined the Nasdaq $3.70
July 17, 2023, $6.19 (~ 14 million shares traded, the market in a "cash frenzy")
Delisted from TSX July 21, 2023, $4.55 ~ 130K shares traded
And continued dropping, now stands at $2.00
I just don't see any other explanation but the market dictates the price. G1945V